Zobrazeno 1 - 10
of 68
pro vyhledávání: '"Karen E. Harman"'
Autor:
Jinmin Lee, Victoria P. Werth, Russell P. Hall, Rüdiger Eming, Janet A. Fairley, David C. Fajgenbaum, Karen E. Harman, Marcel F. Jonkman, Neil J. Korman, Ralf J. Ludwig, Dedee F. Murrell, Philippe Musette, Haley B. Naik, Christian D. Sadik, Jun Yamagami, Marc L. Yale, Aimee S. Payne
Publikováno v:
Frontiers in Medicine, Vol 5 (2018)
The 5th Scientific Conference of the International Pemphigus and Pemphigoid Foundation (IPPF), “Pemphigus and Pemphigoid: A New Era of Clinical and Translational Science” was held in Orlando, Florida, on May 15–16, 2018. Scientific sessions cov
Externí odkaz:
https://doaj.org/article/017f83732716464bbb5386b7c005fb6f
Autor:
Yana Vinogradova, Julia Hippisley-Cox, Sonia Gran, Sinéad M Langan, Monica S M Persson, Karen E Harman, Kim S Thomas
Publikováno v:
BMJ Open, Vol 10, Iss 7 (2020)
Objectives The validity of bullous pemphigoid and pemphigus vulgaris recording in routinely collected healthcare data in the UK is unknown. We assessed the positive predictive value (PPV) for bullous pemphigoid and pemphigus vulgaris primary care Rea
Externí odkaz:
https://doaj.org/article/83f52502668c4ae997cbab1cccb72b64
Autor:
Karen E Harman, Jag Barha, Jo R Chalmers, John K G Dart, Isobel Davies, Patricia Ellis, Douglas Grindlay, Philip J Hampton, Sharleen Hill, Sharon Hockey, Antonia Lloyd-Lavery, Maggie McPhee, Ruth Murphy, Saaeha Rauz, Jane F Setterfield, Ingrid Thompson, Melanie Westmoreland, Christina Waistell
Publikováno v:
British Journal of Dermatology.
To identify priorities for future research into the treatment of bullous pemphigoid, mucous membrane pemphigoid and pemphigus vulgaris, we conducted a Priority Setting Partnership using James Lind Alliance methodology. The top 10 priorities identifie
Publikováno v:
BMJ Case Rep
We present the case of a 17-year-old Asian man diagnosed with pachydermodactyly, a rare digital fibromatosis. Although this is a non-inflammatory periarticular soft tissue disorder, the clinical appearance can mimic inflammatory arthritis. The patien
Autor:
Monica S M Persson, Sinead Langan, S. Gran, Joanne R Chalmers, Kim S Thomas, Julia Hippisley-Cox, Karen E. Harman, Yana Vinogradova
Publikováno v:
The British Journal of General Practice
BackgroundOral prednisolone is the mainstay treatment for bullous pemphigoid, an autoimmune blistering skin disorder affecting older people. Treatment with moderate-to-high doses is often initiated in secondary care, but then continued in primary car
Publikováno v:
Clinical and Experimental Dermatology
Summary This review is part of a series of annual updates that summarize the evidence base for atopic eczema (AE). The aim is to provide a succinct guide for clinicians on the key findings from 14 systematic reviews on the prevention and topical trea
Autor:
Douglas J.C. Grindlay, Natasha K Rogers, Karen E. Harman, T. Garland, Bayanne Olabi, S. Worboys
Publikováno v:
Clinical and Experimental Dermatology. 45:980-985
This review forms part of an annual update series on atopic eczema (AE), where systematic reviews (SRs) are gathered and appraised to provide a summary of key recent research findings. The focus of this article is systemic therapies used in AE, while
Publikováno v:
The British journal of dermatologyReferences. 186(2)
Bullous pemphigoid (BP) and pemphigus vulgaris (PV) are autoimmune blistering skin disorders which are increasing in incidence and are associated with high mortality. 1,2 As people with BP and PV often have comorbidity and require treatment that has
Publikováno v:
The British journal of dermatologyReferences. 186(3)
BACKGROUND Bullous pemphigoid (BP) is an autoimmune blistering disorder that mainly affects older people. Although the disease is associated with considerable morbidity and mortality, the burden of disease worldwide is unclear. OBJECTIVES The study a
Publikováno v:
Clinical and Experimental Dermatology. 45:929-931